These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Lipoprotein(a): a link between thrombogenesis and atherogenesis]. Vucković B; Derić M Med Pregl; 2007; 60(1-2):37-41. PubMed ID: 17853709 [TBL] [Abstract][Full Text] [Related]
4. The role of lipoprotein(a) in atherogenesis and thrombosis. Hajjar KA; Nachman RL Annu Rev Med; 1996; 47():423-42. PubMed ID: 8712793 [TBL] [Abstract][Full Text] [Related]
5. [Lipoprotein(a): a link between thrombosis and atherosclerosis?]. Hansen PR Ugeskr Laeger; 1993 May; 155(20):1527-30. PubMed ID: 8316983 [TBL] [Abstract][Full Text] [Related]
6. Experimental Animal Models Evaluating the Causal Role of Lipoprotein(a) in Atherosclerosis and Aortic Stenosis. Yeang C; Cotter B; Tsimikas S Cardiovasc Drugs Ther; 2016 Feb; 30(1):75-85. PubMed ID: 26780907 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein(a) Antisense Oligonucleotides: A New Treatment Option for Lowering Elevated Lipoprotein(a)? Schreml J; Gouni-Berthold I Curr Pharm Des; 2017; 23(10):1562-1570. PubMed ID: 28128058 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. Tsimikas S; Hall JL J Am Coll Cardiol; 2012 Aug; 60(8):716-21. PubMed ID: 22898069 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a), cardiovascular disease, and contemporary management. Jacobson TA Mayo Clin Proc; 2013 Nov; 88(11):1294-311. PubMed ID: 24182706 [TBL] [Abstract][Full Text] [Related]
10. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?]. de Brouckère V; Liénart F; Ducobu J Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a) catabolism: a case of multiple receptors. McCormick SPA; Schneider WJ Pathology; 2019 Feb; 51(2):155-164. PubMed ID: 30595508 [TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models. Boffa MB; Marcovina SM; Koschinsky ML Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247 [TBL] [Abstract][Full Text] [Related]
14. Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease. Ma L; Waldmann E; Ooi EMM; Chan DC; Barrett HPR; Watts GF; Parhofer KG Eur J Clin Invest; 2019 Feb; 49(2):e13053. PubMed ID: 30447089 [TBL] [Abstract][Full Text] [Related]
15. Hyperlipoproteinaemia(a) - apheresis and emerging therapies. Vogt A Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):12-17. PubMed ID: 28185213 [TBL] [Abstract][Full Text] [Related]
16. The impact of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a): Objectives and methods of a randomised controlled trial. Khan TZ; Pottle A; Pennell DJ; Barbir MS Atheroscler Suppl; 2015 May; 18():103-8. PubMed ID: 25936312 [TBL] [Abstract][Full Text] [Related]